The leader polypeptide of Theiler's virus is essential for neurovirulence but not for virus growth in BHK cells
暂无分享,去创建一个
[1] R. Grant,et al. A single amino acid change determines persistence of a chimeric Theiler's virus , 1994, Journal of virology.
[2] W. Kong,et al. Involvement of cardiovirus leader in host cell-restricted virus expression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] R. Fujinami,et al. Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease , 1994, Journal of virology.
[4] J. Peterson,et al. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. , 1994, Journal of immunology.
[5] R. Roos,et al. Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence , 1993, Journal of virology.
[6] K. Jensen,et al. A single base deletion in the 5' noncoding region of Theiler's virus attenuates neurovirulence , 1992, Journal of virology.
[7] R. Roos,et al. Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses , 1992, Journal of virology.
[8] K. Jensen,et al. The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence , 1991, Journal of virology.
[9] W. Kong,et al. Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus , 1991, Journal of virology.
[10] R. Fujinami,et al. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection , 1991, Journal of virology.
[11] R. Roos,et al. Strains from both Theiler's virus subgroups encode a determinant for demyelination , 1990, Journal of virology.
[12] B. Semler,et al. Neurovirulence determinants of genetically engineered Theiler viruses. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[13] H. Lipton,et al. Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[14] B. Semler,et al. Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus , 1989, Journal of virology.
[15] B. Semler,et al. Polyprotein processing of Theiler's murine encephalomyelitis virus , 1989, Journal of virology.
[16] R. Fujinami,et al. Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus , 1989, The Journal of experimental medicine.
[17] R. Lloyd,et al. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex , 1988, Journal of virology.
[18] J. Borkowski,et al. Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. , 1988, Virology.
[19] S. Miller,et al. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains. , 1987, Microbial pathogenesis.
[20] H. Lipton,et al. Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses , 1987, Journal of virology.
[21] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[22] G. Parks,et al. Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5' noncoding sequences to the P3 region , 1986, Journal of virology.
[23] E. Beck,et al. A second protease of foot-and-mouth disease virus , 1986, Journal of virology.
[24] A. Haase,et al. Simultaneous in situ detection of viral RNA and antigens. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Lipton,et al. Theiler's virus antigen detected in mouse spinal cord 2½ years after infection , 1984, Neurology.
[26] H. Lipton,et al. Replication of Theiler's murine encephalomyelitis viruses in BHK21 cells: an electron microscopic study. , 1980, Virology.
[27] H. Lipton,et al. The TO strains of Theiler's viruses cause “slow virus—like” infections in mice , 1979, Annals of neurology.
[28] P. Tegtmeyer,et al. Identification of simian virus 40 protein A , 1977, Journal of virology.
[29] H. Lipton,et al. Chronic neurologic disease in Theiler's virus infection of SJL/J mice , 1976, Journal of the Neurological Sciences.
[30] F. Hochberg,et al. Demyelinative myelopathy in mice induced by the DA virus , 1976, Journal of the Neurological Sciences.
[31] H. Lipton. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination , 1975, Infection and immunity.
[32] M. Theiler,et al. ENCEPHALOMYELITIS OF MICE : I. CHARACTERISTICS AND PATHOGENESIS OF THE VIRUS. , 1940 .
[33] M. Theiler,et al. ENCEPHALOMYELITIS OF MICE , 1940, The Journal of experimental medicine.
[34] H. Lipton. Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. , 1980, The Journal of general virology.